The Role of Circulating Tumour DNA as a Marker of Adequate Resection in Oral Cancer and its Correlation with Clinico-pathologic Parameters: A Prospective Study by Akhlak Husain, Ashish Singhal, Akash Agarwal, Rahat Hadi, Nuzhat Husain

Subjects: Get full text

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer by Quisette P. Janssen, Eileen M. O'Reilly, Eileen M. O'Reilly, Casper H. J. van Eijck, Bas Groot Koerkamp

Subjects: Get full text

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer by Julia E. Douglas, Suyu Liu, Junsheng Ma, Robert A. Wolff, Shubham Pant, Anirban Maitra, Eric P. Tamm, Priya Bhosale, Matthew H. G. Katz, Gauri R. Varadhachary, Eugene J. Koay

Subjects: Get full text

The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiother... by Zhang H, Lin J, Huang Y, Chen Y

Subjects: Get full text

Radiochemotherapy in Pancreatic Cancer by Małgorzata Domagała-Haduch, Anita Gorzelak-Magiera, Łukasz Michalecki, Iwona Gisterek-Grocholska

Subjects: Get full text

Clinical presentation and outcomes of pancreatic cancer at a tertiary care hospital in the sub-Himalayan region: A retrospective observational study by Amit Gupta, Deepak Rajput, Shyam Karuppusamy Krishnasamy, Oshin Sharma, Rahul Mishra, Amoli Tandon, Sweety Gupta

Subjects: Get full text

Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database by Yan-qing Wang, Xu-dong Liu, Wen-liang Bai, Shan-qing Li

Subjects: Get full text

Eluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study by Zhou Jessica, Hruban Ralph H, Laheru Dan, Pawlik Timothy M, Bhatia Sumita, Hsu Charles C, Miller Robert C, Narang Amol K, Winter Jordan M, Haddock Michael G, Donohue John H, Schulick Richard D, Wolfgang Christopher L, Cameron John L, Herman Joseph M

Subjects: Get full text

Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma by Wade Christopher, Sean Nassoiy, Rebecca Marcus, Jennifer Keller, Shu-Ching Chang, Trevan Fischer, Anton Bilchik, Melanie Goldfarb

Subjects: Get full text

Prognosis of Neoadjuvant HAIC and Lenvatinib Followed by Surgery versus Direct Resection for Resectable or Borderline Resectable Hepatocellular Carcinoma: A Real-World Study by Shi Y, Chen K, Li X, Li X, Feng X, Wu X, Qi S, Shi Z

Subjects: Get full text

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma by Joel Ho, Jane Mattei, Michael Tetzlaff, Michelle D. Williams, Michael A. Davies, Adi Diab, Isabella C. Glitza Oliva, Jennifer McQuade, Sapna P. Patel, Hussein Tawbi, Michael K. Wong, Sarah B. Fisher, Ehab Hanna, Emily Z. Keung, Merrick Ross, Roi Weiser, Shirley Y. Su, Michael Frumovitz, Larissa A. Meyer, Amir Jazaeri, Curtis A. Pettaway, B. Ashleigh Guadagnolo, Andrew J. Bishop, Devarati Mitra, Ahsan Farooqi, Roland Bassett, Silvana Faria, Priyadharsini Nagarajan, Rodabe N. Amaria

Subjects: Get full text

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer by Sung J. Ma, Austin J. Iovoli, Gregory M. Hermann, Kavitha M. Prezzano, Anurag K. Singh

Subjects: Get full text

Adjuvant and neo‐adjuvant immunotherapy in resectable non‐small cell lung cancer (NSCLC): Current status and perspectives by Ziyi Xu, Zihua Zou, Xuezhi Hao, Puyuan Xing, Junling Li

Subjects: Get full text

Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma by M. Brugel, O. Bouché, R. Kianmanesh, L. Teuma, A. Tashkandi, J. M. Regimbeau, P. Pessaux, B. Royer, R. Rhaiem, C. Perrenot, C. Neuzillet, T. Piardi, S. Deguelte

Subjects: Get full text

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality! by Vijay Maruti Patil, Vanita Noronha, Amit Joshi, Amit Kumar, Hollis Dsouza, Atanu Bhattacharjee, Abhishek Mahajan, Nilesh Sabale, Sarbani Ghosh-Laskar, Kumar Prabhash

Subjects: “…borderline resectable…”
Get full text

Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching ana... by Chih-Chieh Yen, Yan-Shen Shan, Ying-Jui Chao, Ting-Kai Liao, I-Shu Chen, Hsuan-Yi Huang, I-Ting Liu, Chia-Jui Yen

Subjects: Get full text

The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer by Xin Luo, Xianchao Lin, Ronggui Lin, Yuanyuan Yang, Congfei Wang, Haizong Fang, Heguang Huang, Fengchun Lu

Subjects: “…Resectable pancreatic cancer…”
Get full text

Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre rando... by Knut Jørgen Labori, Kristoffer Lassen, Dag Hoem, Jon Erik Grønbech, Jon Arne Søreide, Kim Mortensen, Rune Smaaland, Halfdan Sorbye, Caroline Verbeke, Svein Dueland

Subjects: “…Resectable pancreatic cancer…”
Get full text

Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer by Andras Piffko, Andras Piffko, Andras Piffko, Benedikt Asey, Lasse Dührsen, Inka Ristow, Johannes Salamon, Harriet Wikman, Cecile L. Maire, Katrin Lamszus, Manfred Westphal, Thomas Sauvigny, Malte Mohme

Subjects: Get full text

Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review by Lavinia Gatteschi, Mauro Iannopollo, Alessandro Gonfiotti

Subjects: “…resectable NSCLC…”
Get full text